United Therapeutics and Deka Research and Development have received FDA 510(k) clearance for the co-developed RemUnity system.
The RemUnity system is a subcutaneous delivery system for Remodulin injections. The two companies have co-developed the device that is indicated to treat pulmonary arterial hypertension.
{iframe}https://www.massdevice.com/fda-clears-remunity-drug-pump-co-developed-by-deka-united-therapeutics/{/iframe}